| Home | E-Submission | Sitemap | Contact Us |  
top_img
Cancer Research and Treatment > Accepted Articles
doi: https://doi.org/10.4143/crt.2021.325    [Accepted]
Life-Sustaining Treatment States in Korean Cancer Patients After Enforcement of Act on Decisions on Life-Sustaining Treatment for Patients at the End of Life
Young-Woong Won1, Hwa Jung Kim2, Jung Hye Kwon3, Ha Yeon Lee4, Sun Kyung Baek5, Yu Jung Kim6, Do Yeun Kim7, Hyewon Ryu8
1Division of Hematology and Oncology, Department of Internal Medicine, Hanyang University Guri Hospital, Hanyang University College of Medicine, Seoul, Korea
2Department of Preventive Medicine, Ulsan University College of Medicine, Seoul, Korea
3Division of Hematology and Oncology, Department of Internal Medicine, Chungnam National University Sejong Hospital, Chungnam National University College of Medicine,, Chungnam, Korea
4Division of Hematology and Oncology, Department of Internal Medicine, National Medical Center, Seoul, Korea
5Division of Hematology and Oncology, Department of Internal Medicine, Kyung Hee University College of Medicine, Seoul, Korea
6Division of Hematology and Medical Oncology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea
7Department of Internal Medicine, Dongguk University Ilsan Hospital, Goyang, Korea
8Division of Hematology and Oncology, Department of Internal Medicine, Chungnam National University Hospital, Chungnam National University College of Medicine, Daejeon, Korea
Correspondence  Jung Hye Kwon ,Tel: 82-44-995-4781, Fax: 82-44-995-4782, Email: kwonjhye.onco@gmail.com
Received: March 12, 2021;  Accepted: May 31, 2021.  Published online: June 2, 2021.
*Young-Woong Won and Hwa Jung Kim contributed equally to this work.
ABSTRACT
Purpose
In Korea, the “Act on Hospice and Palliative Care and Decisions on life-sustaining treatment (LST) for Patients at the End of Life” was enacted on February 4, 2018. This study was conducted to analyze the current state of LST decisions based on National Health Insurance Service (NHIS) data after the law came into force.
Materials and Methods
The data of 173,028 cancer deaths were extracted from NHIS qualification data between November 2015 and January 2019.
Results
The number of cancer deaths complied with the law process was 14,438 of 54,635 cases (26.4%). The rate of patient self-determination was 49.0%. The patients complying with the law process have used a hospice center more frequently (28% vs. 14%). However, the rate of intensive care unit admission (ICU) was similar between the patients who complied with and without the law process (ICU admission 23% vs. 21%). There was no difference in the proportion of patients who had undergone mechanical ventilation and hemodialysis in the comparative analysis before and after the enforcement of the law and the analysis according to the compliance with the law. The patients who complied with the law process received cardiopulmonary resuscitation at a lower rate.
Conclusion
The law has positive effects on the rate of life-sustaining treatment decision by patient’s determination. However, there was no sufficient effect on the withholding or withdrawing of life-sustaining treatment, which could protect the patient from unnecessary or harmful interventions.
Key words: Life-sustaining treatment, Life-sustaining treatment decisions law, Cancer deaths
Editorial Office
Korean Cancer Association
Room 1824, Gwanghwamun Officia
92 Saemunan-ro, Jongno-gu, Seoul 03186, Korea
TEL: +82-2-3276-2410   FAX: +82-2-792-1410   E-mail: journal@cancer.or.kr
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Copyright © Korean Cancer Association.                 Developed in M2PI